लोड हो रहा है...
Enhanced Mesenchymal Stromal Cells or Erythropoietin Provide Long-term Functional Benefit after Neonatal Stroke
BACKGROUND AND PURPOSE: Perinatal stroke is a common cause of life-long neurobehavioral compromise. Mesenchymal stromal cells (MSC) and erythropoietin (EPO) have each demonstrated short-term benefit with delayed administration after stroke, and combination therapy may provide the most benefit. The p...
में बचाया:
| में प्रकाशित: | Stroke |
|---|---|
| मुख्य लेखकों: | , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2020
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7770074/ https://ncbi.nlm.nih.gov/pubmed/33349013 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.120.031191 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|